Home
About Us
Platforms
Programs
Careers
Media
Contact
Microbiome Times: Locus Biosciences Enters Collaboration and License Agreement with J&J to Develop CRISPR-Cas3 Bacteriophage Therapeutics
Posted on January 4, 2019 by
bkfrye
-
News